Málaga Rodríguez, Germán Javier; Ruiz, Eloy F.
(Elsevier, 2019)
Evidence that sodium-glucose co-transporter-2 inhibitors (SGLT2i) can reduce cardiovascular risk—with trials showing reductions in cardiovascular death, myocardial infarction, and stroke—would suggest they have much to ...